{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:50:47Z","timestamp":1778615447224,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":3121,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1074\/jbc.m111.279133","type":"journal-article","created":{"date-parts":[[2012,1,21]],"date-time":"2012-01-21T02:41:23Z","timestamp":1327113683000},"page":"8641-8651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Phosphorylation of Amyloid-\u03b2 Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes"],"prefix":"10.1016","volume":"287","author":[{"given":"Sathish","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9sir\u00e9e","family":"Hinze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaele","family":"Josten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Sahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Siepmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M111.279133_bib1","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awl251","article-title":"Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A\u03b2 amyloid pathway","volume":"129","author":"Masters","year":"2006","journal-title":"Brain"},{"key":"10.1074\/jbc.M111.279133_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-2001-3111","article-title":"Alzheimer disease results from the cerebral accumulation and cytotoxicity of amyloid-\u03b2 protein","volume":"3","author":"Selkoe","year":"2001","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.279133_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","article-title":"The secretases: enzymes with therapeutic potential in Alzheimer disease","volume":"6","author":"De Strooper","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1074\/jbc.M111.279133_bib4","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.286.5441.916","article-title":"The presenilins in Alzheimer disease: proteolysis holds the key","volume":"286","author":"Haass","year":"1999","journal-title":"Science"},{"key":"10.1074\/jbc.M111.279133_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0166-2236(89)90055-6","article-title":"Molecular genetic approaches to Alzheimer disease","volume":"12","author":"Tanzi","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3940(96)12587-8","article-title":"Three different mutations of presenilin-1 gene in early-onset Alzheimer disease families","volume":"208","author":"Kamino","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.M111.279133_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1749-6632.1993.tb23052.x","article-title":"Alzheimer disease families with amyloid precursor protein mutations","volume":"695","author":"Rossor","year":"1993","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1074\/jbc.M111.279133_bib8","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS \u03b2-amyloid in Alzheimer disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.1074\/jbc.M111.279133_bib9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/nm1438","article-title":"Human amyloid-\u03b2 synthesis and clearance rates as measured in cerebrospinal fluid in vivo","volume":"12","author":"Bateman","year":"2006","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.M111.279133_bib10","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-\u03b2 metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1874609811003030219","article-title":"Clearance of amyloid-\u03b2 peptide across the choroid plexus in Alzheimer disease","volume":"3","author":"Alvira-Botero","year":"2010","journal-title":"Curr. Aging Sci."},{"key":"10.1074\/jbc.M111.279133_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-\u03b2 peptide across the blood-brain barrier: implication for therapies in Alzheimer disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1074\/jbc.M111.279133_bib13","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","article-title":"Microglia mediate the clearance of soluble A\u03b2 through fluid-phase macropinocytosis","volume":"29","author":"Mandrekar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2005-7304","article-title":"Ineffective phagocytosis of amyloid-\u03b2 by macrophages of Alzheimer disease patients","volume":"7","author":"Fiala","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.279133_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/exnr.1997.6738","article-title":"Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer disease","volume":"149","author":"DeWitt","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1074\/jbc.M111.279133_bib16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/156720207782446315","article-title":"Clearance of amyloid-\u03b2 peptide by neuronal and non-neuronal cells: proteolytic degradation by secreted and membrane-associated proteases","volume":"4","author":"Panchal","year":"2007","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1074\/jbc.M111.279133_bib17","doi-asserted-by":"crossref","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","article-title":"Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-\u03b2 peptide catabolism","volume":"26","author":"Yin","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-0102(02)00015-9","article-title":"A\u03b2-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with A\u03b2 pathology","volume":"43","author":"Fukami","year":"2002","journal-title":"Neurosci. Res."},{"key":"10.1074\/jbc.M111.279133_bib19","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1523\/JNEUROSCI.20-05-01657.2000","article-title":"Neurons regulate extracellular levels of amyloid-\u03b2 protein via proteolysis by insulin-degrading enzyme","volume":"20","author":"Vekrellis","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2005.01.004","article-title":"Insulin, insulin-degrading enzyme, and amyloid-\u03b2 peptide in Alzheimer disease: review and hypothesis","volume":"27","author":"Qiu","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.M111.279133_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1254\/fpj.122.5","article-title":"Amyloid-\u03b2 peptide metabolism and Alzheimer disease","volume":"122","author":"Iwata","year":"2003","journal-title":"Nippon Yakurigaku Zasshi"},{"key":"10.1074\/jbc.M111.279133_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1332.001","article-title":"Targeting amyloid-degrading enzymes as therapeutic strategies in neurodegeneration","volume":"1035","author":"Turner","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1074\/jbc.M111.279133_bib23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1042\/BST0331101","article-title":"A\u03b2-degrading enzymes: modulators of Alzheimer disease pathogenesis and targets for therapeutic intervention","volume":"33","author":"Eckman","year":"2005","journal-title":"Biochem. Soc. Trans."},{"key":"10.1074\/jbc.M111.279133_bib24","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1074\/jbc.272.10.6641","article-title":"Degradation of amyloid-\u03b2 protein by a metalloprotease secreted by microglia and other neural and non-neural cells","volume":"272","author":"Qiu","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8227(85)80026-7","article-title":"Characterization of an insulin-degrading enzyme from cultured human lymphocytes","volume":"1","author":"Roth","year":"1985","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1074\/jbc.M111.279133_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-1326-4-4","article-title":"Insulin-degrading enzyme is exported via an unconventional protein secretion pathway","volume":"4","author":"Zhao","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"10.1074\/jbc.M111.279133_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-2010-1206","article-title":"Insulin-degrading enzyme sorting in exosomes: A secretory pathway for a key brain amyloid-\u03b2 degrading protease","volume":"19","author":"Bulloj","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.279133_bib28","doi-asserted-by":"crossref","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","article-title":"Statins promote the degradation of extracellular amyloid-\u03b2 peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion","volume":"285","author":"Tamboli","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib29","doi-asserted-by":"crossref","first-page":"22711","DOI":"10.1074\/jbc.C110.217893","article-title":"Functional relevance of a novel SlyX motif in nonconventional secretion of insulin-degrading enzyme","volume":"286","author":"Glebov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib30","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid-\u03b2 protein, and the \u03b2-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.279133_bib31","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0002-9440(10)63229-4","article-title":"Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid-\u03b2 protein","volume":"164","author":"Farris","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1074\/jbc.M111.279133_bib32","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1073\/pnas.1031520100","article-title":"Amyloid-\u03b2 peptide levels in brain are inversely correlated with insulysin activity levels in vivo","volume":"100","author":"Miller","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.279133_bib33","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0896-6273(03)00787-6","article-title":"Enhanced proteolysis of \u03b2-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death","volume":"40","author":"Leissring","year":"2003","journal-title":"Neuron"},{"key":"10.1074\/jbc.M111.279133_bib34","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/emboj.2011.138","article-title":"Extracellular phosphorylation of the amyloid-\u03b2 peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer disease","volume":"30","author":"Kumar","year":"2011","journal-title":"EMBO J."},{"key":"10.1074\/jbc.M111.279133_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.18632\/aging.100362","article-title":"Phosphorylation of amyloid-\u03b2 (A\u03b2) peptides: a trigger for formation of toxic aggregates in Alzheimer disease","volume":"3","author":"Kumar","year":"2011","journal-title":"Aging"},{"key":"10.1074\/jbc.M111.279133_bib36","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","article-title":"Insulin-degrading enzyme regulates extracellular levels of amyloid-\u03b2 protein by degradation","volume":"273","author":"Qiu","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer amyloid-\u03b2 peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1074\/jbc.M111.279133_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/jpet.108.140327","article-title":"Dynamics of A\u03b2 turnover and deposition in different \u03b2-amyloid precursor protein transgenic mouse models following \u03b3-secretase inhibition","volume":"327","author":"Abramowski","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1074\/jbc.M111.279133_bib39","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2174\/138161208784705487","article-title":"The role of the cell-surface LRP and soluble LRP in blood-brain barrier A\u03b2 clearance in Alzheimer disease","volume":"14","author":"Deane","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1074\/jbc.M111.279133_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1749-6632.1992.tb27480.x","article-title":"An endosomal-lysosomal pathway for degradation of amyloid precursor protein","volume":"674","author":"Cole","year":"1992","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1074\/jbc.M111.279133_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0197-4580(88)80013-7","article-title":"Effect of aging on the blood-brain barrier","volume":"9","author":"Mooradian","year":"1988","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.M111.279133_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/156720511795256080","article-title":"The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer disease: neuropathological, epidemiological, and genetic evidence","volume":"8","author":"Eikelenboom","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1074\/jbc.M111.279133_bib43","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clin. Invest. Med."},{"key":"10.1074\/jbc.M111.279133_bib44","doi-asserted-by":"crossref","first-page":"36621","DOI":"10.1074\/jbc.M006170200","article-title":"Degradation of amylin by insulin-degrading enzyme","volume":"275","author":"Bennett","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib45","doi-asserted-by":"crossref","first-page":"11552","DOI":"10.1074\/jbc.M007988200","article-title":"Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity","volume":"276","author":"Fawcett","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib46","first-page":"608","article-title":"Insulin degradation: progress and potential","volume":"19","author":"Duckworth","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1074\/jbc.M111.279133_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0968-0004(01)01876-X","article-title":"Insulin-degrading enzyme: embarking on amyloid destruction","volume":"26","author":"Kurochkin","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1074\/jbc.M111.279133_bib48","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature05143","article-title":"Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism","volume":"443","author":"Shen","year":"2006","journal-title":"Nature"},{"key":"10.1074\/jbc.M111.279133_bib49","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1073\/pnas.96.4.1391","article-title":"Phosphorylation of presenilin-2 regulates its cleavage by caspases and retards progression of apoptosis","volume":"96","author":"Walter","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1074\/jbc.M111.279133_bib50","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1074\/jbc.M306653200","article-title":"Phosphorylation of presenilin-1 at the caspase recognition site regulates its proteolytic processing and the progression of apoptosis","volume":"279","author":"Fluhrer","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-2006-9S326","article-title":"Tau phosphorylation and proteolysis: insights and perspectives","volume":"9","author":"Johnson","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1074\/jbc.M111.279133_bib52","doi-asserted-by":"crossref","first-page":"58406","DOI":"10.1155\/JBB\/2006\/58406","article-title":"\u03b2-Amyloid degradation and Alzheimer disease","volume":"2006","author":"Wang","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1074\/jbc.M111.279133_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.2002.00855.x","article-title":"Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?","volume":"81","author":"Carson","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1074\/jbc.M111.279133_bib54","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1523\/JNEUROSCI.4792-03.2004","article-title":"Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-\u03b2 peptide in mouse brain","volume":"24","author":"Iwata","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib55","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.peptides.2007.09.015","article-title":"In vitroin vivo degradation of A\u03b2 peptide by peptidases coupled to erythrocytes","volume":"28","author":"Liu","year":"2007","journal-title":"Peptides"},{"key":"10.1074\/jbc.M111.279133_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0196-9781(95)00021-B","article-title":"Neutral endopeptidase can hydrolyze \u03b2-amyloid(1\u201340) but shows no effect on \u03b2-amyloid precursor protein metabolism","volume":"16","author":"Howell","year":"1995","journal-title":"Peptides"},{"key":"10.1074\/jbc.M111.279133_bib57","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.nbd.2008.06.001","article-title":"Aggregation and catabolism of disease-associated intra-A\u03b2 mutations: reduced proteolysis of A\u03b2 A21G by neprilysin","volume":"31","author":"Betts","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.M111.279133_bib58","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharmthera.2005.03.010","article-title":"Metabolism of amyloid-\u03b2 peptide and Alzheimer disease","volume":"108","author":"Iwata","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1074\/jbc.M111.279133_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brainres.2010.08.025","article-title":"Plasminogen and plasmin in Alzheimer disease","volume":"1355","author":"Barker","year":"2010","journal-title":"Brain Res."},{"key":"10.1074\/jbc.M111.279133_bib60","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1160\/TH04-12-0838","article-title":"Tissue plasminogen activator in central nervous system physiology and pathology","volume":"93","author":"Melchor","year":"2005","journal-title":"Thromb Haemost."},{"key":"10.1074\/jbc.M111.279133_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1471-4914(03)00050-9","article-title":"Emotions are building up in the field of extracellular proteolysis","volume":"9","author":"Madani","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1074\/jbc.M111.279133_bib62","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1523\/JNEUROSCI.20-11-03937.2000","article-title":"The plasmin system is induced by and degrades amyloid-\u03b2 aggregates","volume":"20","author":"Tucker","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib63","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1046\/j.1471-4159.2000.0752172.x","article-title":"Tissue plasminogen activator requires plasminogen to modulate amyloid-\u03b2 neurotoxicity and deposition","volume":"75","author":"Tucker","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1074\/jbc.M111.279133_bib64","first-page":"73","article-title":"ACE variants and association with brain A\u03b2 levels in Alzheimer disease","volume":"3","author":"Miners","year":"2010","journal-title":"Am. J. Transl. Res."},{"key":"10.1074\/jbc.M111.279133_bib65","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/5009","article-title":"Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease","volume":"21","author":"Kehoe","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.279133_bib66","first-page":"163","article-title":"Angiotensin-converting enzyme levels and activity in Alzheimer disease: differences in brain and cerebrospinal fluid ACE and association with ACE1 genotypes","volume":"1","author":"Miners","year":"2009","journal-title":"Am. J. Transl. Res."},{"key":"10.1074\/jbc.M111.279133_bib67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/gepi.20294","article-title":"Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis","volume":"32","author":"Thornton-Wells","year":"2008","journal-title":"Genet. Epidemiol."},{"key":"10.1074\/jbc.M111.279133_bib68","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33, and CD2AP are associated with Alzheimer disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.279133_bib69","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"key":"10.1074\/jbc.M111.279133_bib70","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33, and EPHA1 are associated with late-onset Alzheimer disease","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1074\/jbc.M111.279133_bib71","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1460-9568.2005.03912.x","article-title":"The N-terminal active center of human angiotensin-converting enzyme degrades Alzheimer amyloid-\u03b2 peptide","volume":"21","author":"Oba","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.M111.279133_bib72","doi-asserted-by":"crossref","first-page":"37644","DOI":"10.1074\/jbc.M508460200","article-title":"Amyloid-\u03b2 protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor","volume":"280","author":"Hemming","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib73","doi-asserted-by":"crossref","first-page":"47863","DOI":"10.1074\/jbc.M104068200","article-title":"Angiotensin-converting enzyme degrades Alzheimer amyloid-\u03b2 peptide (A\u03b2); retards A\u03b2 aggregation, deposition, fibril formation; and inhibits cytotoxicity","volume":"276","author":"Hu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1074\/jbc.M111.279133_bib74","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/0-387-23226-5_20","article-title":"Phosphorylated amyloid-\u03b2: the toxic intermediate in Alzheimer disease neurodegeneration","volume":"38","author":"Milton","year":"2005","journal-title":"Subcell. Biochem."},{"key":"10.1074\/jbc.M111.279133_bib75","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1097\/00001756-200112040-00047","article-title":"Phosphorylation of amyloid-\u03b2 at the serine 26 residue by human Cdc2 kinase","volume":"12","author":"Milton","year":"2001","journal-title":"Neuroreport"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820610080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820610080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M111.279133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T14:11:01Z","timestamp":1674915061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820610080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0021925820610080"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m111.279133","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphorylation of Amyloid-\u03b2 Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.M111.279133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2012 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}